MEDIA

NEWS ARCHIVES

Living with a Central Venous Catheter: Complications and Catheter Reactions
For the past 5 years, I have lived with a peripherally inserted central catheter (PICC) for treatment of a chronic urinary tract infection(UTI) associated with a neurogenic bladder. As a child, I experienced several kidney infections before being diagnose

Living with a Central Venous Catheter: Complications and Catheter Reactions For the past 5 years, I have lived with a peripherally inserted central catheter (PICC) for treatment of a chronic urinary tract infection(UTI) associated with a neurogenic bladder. As a child, I experienced several kidney infections before being diagnosed with vesicoureteral reflux, a condition where urine flows back into the kidney from the bladder. The vesicoureteral reflux was surgically corrected, reducing the frequency of my UTIs. Unfortunately, later in life, I began to develop frequent UTIs despite prophylactic oral antibiotics. My condition progressed over time due to multidrug-resistant organisms and episodes of bacteremia requiring hospital stays lasting from 5-52 days, and usually required that I be discharged with a PICC to complete treatment at home. Typically, having a PICC placed is a routine procedure, but for me it was far from normal. I was plagued by complications, including occluded lines, extensive clotting, and unusual skin reactions requiring the lines to be removed or exchanged. As a patient, I didn't expect that the PICC designed to help treat my illness would cause worse complications in my care.

Read complete story here.

ABOUT INTERFACE BIOLOGICS, INC.

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are surface modifying macro-molecules and polymer enabled combination drug delivery devices. IBI, a University of Toronto spinoff, is located at the MaRS Centre in Toronto, Canada. For more information about Interface Biologics, please visit www.interfacebiologics.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Julie Fotheringham - Partner, Hageman Communications

416-951-7988

Julie.fotheringham@hageman.ca

Powered by Innovasium